Drug Shortage Report for BREVIBLOC PREMIXED INJECTION

Last updated on 2020-01-03 History
Report ID 101500
Drug Identification Number 02309238
Brand name BREVIBLOC PREMIXED INJECTION
Common or Proper name esmolol hydrochloride
Company Name BAXTER CORPORATION
Market Status MARKETED
Active Ingredient(s) ESMOLOL HYDROCHLORIDE
Strength(s) 10MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 10 units/case (CA2J1415)
ATC code C07AB
ATC description BETA BLOCKING AGENTS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2019-12-17
Actual start date 2019-12-17
Estimated end date 2020-01-02
Actual end date 2020-01-02
Shortage status Resolved
Updated date 2020-01-03
Company comments Baxter product BREVIBLOC Injection esmolol hydrochloride Solution, 10 mg/mL (100 mg/10 mL Vials) (DIN: 02188880) is available as an alternative if it aligns with clinical practice.
Health Canada comments
Contact Address 7125 MISSISSAUGA ROAD
MISSISSAUGA, ONTARIO
CANADA L5N 0C2
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2020-01-03 French Compare
v4 2020-01-03 English Compare
v3 2019-12-18 English Compare
v2 2019-12-17 French Compare
v1 2019-12-17 English Compare